Kezar Life Sciences, Inc. (KZR) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Kezar Life Sciences, Inc. (KZR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $53.9M, listed on NASDAQ, employing roughly 55 people, carrying a beta of 0.41 to the broader market. Kezar Life Sciences, Inc. Led by Christopher J. Kirk, public since 2018-06-21.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for KZR as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →